...first-day rise of 29% was the biggest, while Fusion gave back its early gains and PolyPid...
...Life Sciences. Underwriters are Morgan Stanley, Jefferies, Cowen and Wedbush PacGrow (see “Radio Fusion” ). PolyPid Ltd....
...IGF1R (CD221) - Insulin-like growth factor-1 receptor OTOF - Otoferlin Paul Bonanos, Associate Editor Akouos Inc. Fusion Pharmaceuticals Inc. PolyPid Ltd....

...it filed last week to sell 8.4 million shares. Also expected to price Thursday is PolyPid Ltd....

...at the midpoint, the hearing loss gene therapy company would be valued at $424.7 million. PolyPid Ltd....
...Targets WNT - Wingless-type MMTV integration site family Elizabeth S. Eaton, Staff Writer Illumina Inc. Fusion Pharmaceuticals Inc. Akouos Inc. PolyPid Ltd. Amryt...

...Fusion Pharmaceuticals Inc.; and diagnostics companies Genetron Holdings Ltd. and ArcherDX Inc. Drug delivery company PolyPid Ltd....
...LLC Burning Rock Biotech Royalty Pharma Legend Biotechnology Corp. Arya Sciences Acquisition Corp. Lantern Pharma Inc. Akouos Inc. Fusion Pharmaceuticals Inc. Genetron Holdings Ltd. PolyPid Ltd. IPO...

...shares. Underwriters are Jefferies, Cowen, Guggenheim, Baird and Bloom Burton. PolyPid closes $50M series E-1 PolyPid Ltd....
...a broad-spectrum antibiotic to prevent surgical site infections, in two Phase III trials. BC Staff D-PLEX EAL BrightGene Immunotech Biopharm Ltd. PolyPid Ltd....

...Chaim Hurvitz, who will now head PolyPid's board, and undisclosed other existing shareholders also participated. PolyPid...
...secured antibiotic drug reservoir intended to provide prolonged local protection from infection. In March 2015, PolyPid...

...Drug delivery Date announced: 2015-03-26 Type: IPO Underwriters: Aegis Capital; MLV; Chardan Capital Markets Note: PolyPid...

...anticipates undisclosed milestones in the next few months that could boost its valuation. In January, PolyPid...
...Markets. At $11, it would have raised $20 million and been valued at $106.3 million. PolyPid's...

...BioPharma Inc. (C) 11/24/14 TBD Preclin Inotek Pharmaceuticals Corp. 11/4/14 Up to $86.3M Ph II PolyPid Ltd....